Skip to main content

Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panel

Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panel
By Rebecca Robbins and Carl Zimmer from NYT Business Day https://ift.tt/3rppqvw
Merck & Company Inc, Molnupiravir (Drug), Food and Drug Administration, Coronavirus Omicron Variant, Antibodies, Coronavirus Delta Variant, Clinical Trials, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals)

Comments

Popular posts from this blog

How to End This Pandemic, and Prepare for the Next One

How to End This Pandemic, and Prepare for the Next One By Corinne Purtill from NYT Business Day https://ift.tt/37QYsl3 Coronavirus (2019-nCoV), Vaccination and Immunization, United States

Mystery Fuels Unease in Maine Woods: Who Bought Burnt Jacket Mountain?

Mystery Fuels Unease in Maine Woods: Who Bought Burnt Jacket Mountain? By Jenna Russell, Heather Knight and Sophie Park from NYT U.S. https://ift.tt/a6Ye2Gp Land Use Policies, High Net Worth Individuals, Forests and Forestry, Logging Industry, Real Estate and Housing (Residential), Facebook Inc, Thomas Associates, Zuckerberg, Mark E, Chan, Priscilla, Appalachian Trail, Bangor (Me), Maine, Palo Alto (Calif), Mount Katahdin (Me), Millinocket (Me)